Modes of resistance to anti-angiogenic therapy

Gabriele Bergers(Neurological Surgery), Douglas Hanahan(University of California, San Francisco)

Nature reviews. Cancer

July 24, 2008

10.1038/nrc2442

Cited by 2,921Open Access

Abstract

Related Papers

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

Douglas Hanahan, Judah Folkman|Cell|1996|6.9k

Tumour-educated macrophages promote tumour progression and metastasis

Jeffrey W. Pollard|Nature reviews. Cancer|2004|3.4k

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

Daniel J. Ceradini, Anita R. Kulkarni, Matthew J. Callaghan et al.|Nature Medicine|2004|2.6k

Pegaptanib for Neovascular Age-Related Macular Degeneration

Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham et al.|New England Journal of Medicine|2004|2.3k

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Oriol Casanovas, Daniel J. Hicklin, Gabriele Bergers et al.|Cancer Cell|2005|1.6k